Detection and prediction of local recurrence of maxillary sinus cancer using F-18 FDG PET/CT

Rho, Hee Jeong; Kim, S.-J.; Nam, Hyeong Seok; Kim, B.S.; Kim, I.J.; Kim, Y.-K.; Park, K.

doi:10.1016/j.ejso.2009.10.003

Cited by 5 publications

(3 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Le et al 3 reports an overall incidence of lymph node involvement at diagnosis of 15.5% when only SCC pathology is taken into account. This is consistent with many reports 5,7,9,12,13,23-25 and due to this low number most authors have advocated no elective neck treatment for patients with maxillary sinus carcinoma. However, in the 1990s Paulino et al 7 and Jiang et al 21 began to advocate elective ipsilateral neck irradiation in all patients with SCC due to high incidence of neck relapse associated with SCC histology (28% to 36% in their respective reviews) and the poor prognosis of those who relapsed in the neck 7,21,26 .…”

Section: Elective Management Of the Neck In Maxillary Cancersupporting

confidence: 91%

Management of the neck in maxillary sinus carcinomas

Dooley

Shah²

2015

Current Opinion in Otolaryngology & Head and Neck Surgery

View full text Add to dashboard Cite

Purpose of Review To discuss and review the role for elective treatment of the neck in maxillary squamous cell carcinoma. Improvements in survival have been seen due to improved local therapies and control, therefore the treatment of the neck has become a topic of debate. Recent findings The risk of occult metastases in neck nodes is higher for T 3-4 tumors. The rate of nodal relapse in the N0 neck without elective treatment is 8-15%. With elective irradiation the nodal relapse rate decreases. However, most nodal relapses are accompanied by local failure or distant disease. Local failure remains the most common site of failure and cause of death in this patient population. Summary Treatment failure occurs overall in 62% of all patients, with local recurrence by far the most common site of treatment failure which is rarely amenable to salvage therapy. Therefore elective neck irradiation is not routinely indicated in the clinically N0 neck; those who recur only in the neck can be surgically salvaged more than 50% of the time.

show abstract

Section: Elective Management Of the Neck In Maxillary Cancersupporting

confidence: 91%

Management of the neck in maxillary sinus carcinomas

Dooley

Shah²

2015

Current Opinion in Otolaryngology & Head and Neck Surgery

View full text Add to dashboard Cite

show abstract

“…Rho et al 19 used PET standardized uptake value (SUV) ratios (i.e., lesion to nonlesion, lesion to aorta, and lesion to cerebellum) to detect recurrence in patients with maxillary sinus cancer treated with maxillectomy and adjuvant radiation treatment, citing the difficulty of detecting recurrence after surgery and chemoradiation because of anatomic distortion and posttreatment changes. They reported that when the findings on PET were negative the patients did not have evidence of recurrence on subsequent conventional imaging or clinical examinations.…”

Section: Discussionmentioning

confidence: 99%

Imaging Findings of Recurrent Tumors After Orbital Exenteration and Free Flap Reconstruction

Lee

Sedrak

Guha-Thakurta³

et al. 2014

Ophthalmic Plastic &Amp; Reconstructive Surgery

View full text Add to dashboard Cite

show abstract

“…A total of 7 studies were found discussing the role of PET scan for prognosis in sinonasal malignancies. 27,[34][35][36][37][38][39] A summary of each study, their level of evidence, and an assessment of risk of bias can be found in Table 4. All 7 studies were retrospective and had a serious risk of bias.…”

Section: Sinonasal Carcinomasmentioning

confidence: 99%

The Role of Positron Emission Tomography for the Management of Sinonasal Malignancies: A Systematic Review

El-Adem,

Yang,

Gudis

2023

Am J Rhinol�Allergy

View full text Add to dashboard Cite

Background Positron emission tomography (PET) scan is a valuable imaging modality widely used in the management of cancers. Its usage is well defined for most head and neck malignancies. However, there is a lack of consensus regarding the utility of PET scan for sinonasal malignancies. This is highlighted by the latest international consensus statement on endoscopic skull base surgery. Objective This systematic review aims to clarify the role of PET scan in the management of sinonasal malignancies. Methods We conducted a comprehensive literature search using PubMed, MEDLINE, EMBASE, Web of Science, CINAHL, and Cochrane databases for research studies of interest. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) updated statement was used to guide the review. Results In total, 1807 articles were assessed for eligibility. Thirty-nine original papers, published between 2004 and 2021, met inclusion criteria. Seven articles focused on the role of PET scan for inverted papilloma, 23 for sinonasal carcinoma, 4 for melanoma, and 3 for lymphoma, and finally, 3 articles focused on the use of specific PET scan tracers for sinonasal malignancies. Qualitative summaries for each potential role of PET scans were provided. In general, included studies were retrospective in nature with low level of evidence. Conclusions In general, and across all types of sinonasal malignancies, PET scan yielded positive results regarding detection and initial staging. It was also considered as the modality of choice for detection of distant metastases, except in the case of sinonasal lymphoma. PET scan's main limit resides in its inability to detect lesions in or close to the metabolic activity of the brain.

show abstract

Detection and prediction of local recurrence of maxillary sinus cancer using F-18 FDG PET/CT

Cited by 5 publications

References 25 publications

Management of the neck in maxillary sinus carcinomas

Management of the neck in maxillary sinus carcinomas

Imaging Findings of Recurrent Tumors After Orbital Exenteration and Free Flap Reconstruction

The Role of Positron Emission Tomography for the Management of Sinonasal Malignancies: A Systematic Review

Contact Info

Product

Resources

About